Liquid biopsy markers for stroke diagnosis.
Harshani WijerathneMalgorzata A WitekAlison E BairdSteven A SoperPublished in: Expert review of molecular diagnostics (2020)
While there are a plethora of molecular markers for stroke diagnosis that have been reported, they have yet to be FDA-cleared. Possible reasons include the inability for these markers to appear in sufficient quantities for highly sensitive clinical decisions within the rt-PA therapeutic time.